Sofinnova Partners announced Myricx Bio agrees to be acquired by Novartis Sofinnova Partners, a leading European life sciences venture capital firm, announced that its portfolio company Myricx Bio has reached an agreement to be acquired by Novartis for up to $1.5 billion, including $1.1 billion cash upfront plus potential milestone payments. Sofinnova Partners seeded the […]
Hansa Biopharma announced the closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA Hansa Biopharma AB and SERB S.A. announced that the required regulatory approvals have been obtained and that the previously announced €115 million exclusive licensing transaction with SERB has closed. The company also announced that Maria Törnsén, […]
Investment firms Samsung launched ‘Samsung Life Science Fund 3’, a $145 million fund to invest in global biotech companies and support strategic collaborations THENA Capital closed its inaugural Fund I, at £45 million, to back UK medtech startups, anchored by the British Business Bank Investors Trent Munro appointed Venture Partner at Brandon Capital Karolina […]
The Annual BioBabraham Symposium is a joint initiative between the Babraham Institute and Babraham Research Campus in Cambridge, UK, that brings together academic and commercial stakeholders to highlight the exceptional scientific innovation taking place on campus. Across the day, the Symposium showcased an impressive range of companies, with particularly strong momentum in immunology, spanning target discovery, immunomodulation approaches and ADCs. The programme also highlighted advances in neurological […]
Hansa Biopharma’s ConfIdeS Phase 3 abstract selected for ‘What’s Hot, What’s New’ plenary at ATC 2026 Hansa Biopharma AB, announced on Thursday that the ConfIdeS Phase 3 abstract titled “Superior 1-year eGFR Among Highly Sensitized Patients Desensitized with Imlifidase Compared to Control” had been selected to be highlighted at the closing plenary session “What’s Hot, What’s New” at the American Transplant Congress (ATC) 2026, which took place in Boston on June […]
